The Notch receptor and its ligands are key components in a core metazoan signaling pathway that regulates the spatial patterning, timing and outcome of many cell-fate decisions. Ligands contain a disulfide-rich Delta/Serrate/LAG-2 (DSL) domain required for Notch trans-activation or cis-inhibition. Here we report the X-ray structure of a receptor binding region of a Notch ligand, the DSL-EGF3 domains of human Jagged-1 (J-1 DSL-EGF3 ). The structure reveals a highly conserved face of the DSL domain, and we show, by functional analysis of Drosophila melanogster ligand mutants, that this surface is required for both cis-and trans-regulatory interactions with Notch. We also identify, using NMR, a surface of Notch-1 involved in J-1 DSL-EGF3 binding. Our data imply that cis-and trans-regulation may occur through the formation of structurally distinct complexes that, unexpectedly, involve the same surfaces on both ligand and receptor.
The Notch receptor is part of a core signaling pathway that has been highly conserved in all metazoan species and is required at numerous stages of development 1, 2 . In addition to its role in regulating cell-fate decisions during early life, the Notch receptor is required for maintenance and differentiation of mammalian neural and hemopoietic stem-cell populations in the adult organism 3, 4 . Furthermore it has been shown to have a key role in the development and regulation of the immune system, including the induction of T-cell tolerance 5 . Notch pathway dysfunction is associated with both acquired and inherited disease states in humans 6 .
Notch is a transmembrane protein that undergoes proteolytic processing by furin during its trafficking within the secretory pathway and is subsequently presented at the cell surface as a noncovalently associated heterodimer [7] [8] [9] . Proximal to the membrane are three Lin-12-Notch repeats (LNRs) and a heterodimerization domain. These comprise the extracellular negative regulatory region (NRR), which is important for maintaining the receptor in the 'off' state. A recent atomic structure of this region shows that a tumor necrosis factor-a-converting enzyme (TACE) cleavage site is buried by interdomain interactions, and it has been proposed that significant conformational changes in this region occur upon Notch activation to expose the protease site 10 . The latter may occur, following ligand binding, as a result of endocytosis of the Notch-ligand complex by the ligand-expressing cell, which removes the extracellular moiety of the Notch heterodimer 11, 12 . The remaining, membrane-tethered, Notch fragment on the signal-receiving cell then undergoes two distinct intramembrane proteolytic steps catalyzed by TACE and g-secretase.
Proteolysis results in the release of a soluble intracellular fragment of Notch 13, 14 , which subsequently translocates to the nucleus and binds to a DNA binding protein of the CBF1/Suppressor of Hairless/Lag-1 (CSL) family and its coactivator Mastermind, thus relieving repression of Hairy/Enhancer of split (HES) gene expression 15 . In addition to promoting Notch activation through trans-interactions with the receptor expressed on adjacent cells, Notch ligands can also form cis-inhibitory interactions with Notch expressed in the same cell, limiting the zone of Notch activity [16] [17] [18] [19] [20] .
In D. melanogaster there is a single Notch receptor, whereas in mammals the signaling pathway is more complex, with four Notch receptors (Notch-1-4). The main part of the extracellular region of Notch comprises up to 36 epidermal growth factor (EGF) domains, many of which contain a Ca 2+ binding (cb) consensus sequence 21 . EGF domains 11 and 12 are known to be essential for ligand binding, as is Ca 2+ (ref. 22) . The solution structure of human Notch-1 EGFs 11-13 (N-1 11À13 ) previously demonstrated a rod-like conformation for the N-1 11-12 region, with both Ca 2+ coordination and hydrophobic packing interactions contributing to the extended organization of domains 23 . It is likely that the rod-shaped organization facilitates the formation of a binding surface for proteinprotein interactions, as seen in other proteins with tandem repeats of cbEGF domains 24 .
All Notch ligands contain a variable number of EGF domain repeats and an N-terminal DSL domain. Two ligand families can be distinguished by the presence or absence of a cysteine-rich domain. This gives rise to the Serrate/Jagged ligand family and the Delta/Delta-like ligand family, respectively 21 . In D. melanogaster there is only one ligand of each class (Serrate and Delta), whereas in mammals there are two Serrate-class ligands (Jagged-1 and Jagged-2) and three Delta-like ligands (Dll1, Dll3 and Dll4). Site-directed mutagenesis and deletion analysis was used to demonstrate that the DSL domain confers specificity of binding to Notch and that C-terminal linkage of two EGF domains seems to facilitate binding 18, 25, 26 . Although cellular and in vivo studies have provided considerable insight into the downstream consequences of signaling, and some advances have been made in determining the structure of the Notch receptor, there are no highresolution structural data currently available for the ligands, or for the Notch-ligand complex, to explain how receptor binding and activation occurs. Furthermore, the molecular basis for the productive (trans-activation) and nonproductive (cis-inhibition) interactions is not understood.
In this study, we identify functional fragments of human Notch-1 (N-1) and Jagged-1 (J-1), which interact in a Ca 2+ -dependent manner. We describe the first high-resolution structure of the DSL-EGF3 fragment of human J-1 (J-1 DSL-EGF3 ) and the first crystal structure for the ligand binding region of N-1 (N-1 [11] [12] [13] ). These data, together with NMR titration of 15 N-labeled N-1 [11] [12] [13] with J-1 DSL-EGF3 , allow definition of the face of N-1 involved in ligand binding. An interaction surface on the DSL domain of J-1 is predicted on the basis of our structure and tested using mutagenesis and functional analysis of the DSL domain in the D. melanogaster homolog of J-1, Serrate. These experiments confirm the importance of this DSL surface in both the activation and cis-inhibition of Notch. When these data are combined, using in silico docking of the two protein structures, antiparallel and parallel models for the complex are generated. Molecular modelling thus suggests that, despite our finding that the same region of J-1 is involved in cis-and trans-regulatory activities, the physical basis for these functions may be the formation of two structurally distinct complexes. The results presented therefore provide the atomic structure of the receptor binding region of a Notch ligand, a model for the early molecular events associated with the Notch-Jagged interaction and a basis for the design of selective inhibitors of Notch activity. RESULTS J-1 DSL-EGF3 interacts with N-1 [11] [12] [13] To increase our understanding of the molecular basis of the human Notch-Jagged recognition event, we designed truncated fragments of N-1 and J-1, encompassing the domains that are implicated in binding. These fragments correspond to cbEGFs 11-13 of N-1 (N-1 [11] [12] [13] ) and the DSL and first three EGF domains of J-1 (J-1 DSL-EGF3 ). The N terminus of the DSL domain was defined on the basis of sequence homology between Jagged and Delta-like proteins, as in the Swiss-Prot database 27 . Correct folding of N-1 [11] [12] [13] has been demonstrated previously by determination of the solution structure of this construct 23 . We have now used a similar overexpression and refolding strategy to generate J-1 DSL-EGF3 and an N-1 [11] [12] [13] construct modified by the addition of a biotin ligase (BirA) tag at the C terminus. Addition of the tag was found to increase the efficiency of the refolding of EGF13. We have used pull-down experiments (Fig. 1a,b) and surface plasmon resonance (SPR; Fig. 1c -e) to demonstrate a specific, Ca 2+ -dependent interaction between these constructs, a property of the cell-surface interaction mediated by the full-length proteins.
NMR studies of the Notch-Jagged interaction We investigated complex formation between N-1 [11] [12] [13] and J-1 DSL-EGF3 at the residue-specific level using NMR spectroscopy. Stepwise addition of unlabeled J-1 DSL-EGF3 to a solution of 15 N-labeled N-1 [11] [12] [13] led to a gradual decrease in the intensity of most peaks in the 1 H-15 N HSQC spectra of N-1 [11] [12] [13] . J-1 DSL-EGF3 precipitates at Figure 1 Specific recognition of N-1 [11] [12] [13] by J-1 DSL-EGF3 . (a) Western blot analysis to demonstrate the pull-down of N-1 [11] [12] [13] with His-tagged J-1 DSL-EGF3 on capture with Ni-NTA magnetic agarose beads. Anti-Notch antibody was used for detection. (b) The Ca 2+ dependence of the interaction was demonstrated with biotinylated N-1 11-13 immobilized on Dynabeads M-270 Streptavidin (lanes 1-4) . Samples in lanes 5 and 6 were control beads without N-1 [11] [12] [13] . Detection of His-tagged J-1 DSL-EGF3 by anti-RGS. His HRP conjugate showed that the interaction of N-1 [11] [12] [13] with J-1 DSL-EGF3 occurred in the presence of Ca 2+ and was inhibited by EDTA (E). Anti-Notch antibody confirmed that equivalent amounts of N-1 [11] [12] [13] were eluted from the beads (below). (c) SPR measurements were taken with 7085 RU (response units) of J-1 DSL-EGF3 coupled to the chip surface and N-1 [11] [12] [13] (without the BirA tag) injected over the chip surface at the indicated concentrations in TBS supplemented with 1 mM Ca 2+ . (d) Trace from c corrected relative to the reference cell. (e) To demonstrate the Ca 2+ dependence of the specific interaction, three sequential injections of N-1 [11] [12] [13] at 110 mM were made over the same J-1 DSL-EGF3 surface. The first and last injections were carried out in the buffer described above, and the second injection contained an additional 10 mM EGTA to chelate available Ca 2+ . Interaction of N-1 [11] [12] [13] with the J-1 DSL-EGF3 -coupled surface and with the reference surface are shown by the red and blue traces, respectively. (f) Addition of unlabeled J-1 DSL-EGF3 (0.15 mM) to 15 N-labeled N-1 [11] [12] [13] (0.5 mM) leads to a loss of intensity of NMR peaks following formation of the large complex between the two proteins. The red line is a visual aid to highlight the greater intensity changes for Val453 and Gly472. 35 ; therefore, we were unable to obtain the HSQC spectrum of fully bound N-1 [11] [12] [13] . No measurable changes in chemical shifts were seen in the HSQC spectra, nor did we observe any new peaks arising from the N-1 11-13 -J-1 DSL-EGF3 complex, probably owing to exchange broadening under the conditions studied. The fractional intensity data plotted in Figure 1f are consistent with the participation of B30% of the N-1 11-13 molecules in a higher molecular weight complex with J-1 DSL-EGF3 . The remaining B70% intensity arises from unbound N-1 [11] [12] [13] . Little or no change in intensity was observed for the N and C termini of N-1 [11] [12] [13] (residues 411-413 and 532-543; Fig. 1f ). These residues undergo significant motions on a picosecond timescale 23 , and the linewidths of their peaks are determined, to a large extent, by these independent fast motions. The absence of any change in intensity for these peaks indicates that the dynamics of these N-and C-terminal residues are not affected by the interaction of J-1 DSL-EGF3 with the EGF domains of N-1 [11] [12] [13] . In contrast, Val453 and Gly472 show a larger decrease in peak intensity than most residues (Fig. 1f) . These larger changes arise from exchange contributions for residues of N-1 [11] [12] [13] with the greatest chemical shift differences between the free and bound states; thus, Val453 and Gly472 represent the strongest candidates for residues that lie in or close to the binding site for the J-1 DSL-EGF3 ligand 28 . These residues are located adjacent to one another on one face of EGF12, within the region where the main ligand binding site is predicted to reside 22, 29 .
Structure of J-1 DSL-EGF3 and N-1 [11] [12] [13] To dissect further the J-1 DSL-EGF3 -N-1 11-13 interactions, we determined the X-ray crystallographic structure of each construct. The structure of J-1 DSL-EGF3 , elucidated at a resolution of 2.5 Å ( Fig. 2a and Supplementary  Fig. 1 . The largest truncation in these two domains is in the loop between Cys3 (C3) and Cys4 (C4), a feature that is also present in the EGF domain from the b2 integrin subunit (1l3y).
The DSL domain has a distinct fold ( Fig. 2b ) that has no structural homologs in the Protein Data Bank with an r.m.s. deviation o2.5 Å . It does however have clear structural similarities to an EGF domain, with a double-stranded antiparallel b-sheet immediately preceding the characteristic loop between the final disulfide-bonded cysteine residues. However, although the three EGF domains have the classic pattern of disulfide bonding (C1-C3, C2-C4, C5-C6), the DSL domain, which also contains six cysteine residues, adopts a fold with a different disulfide-bonded pattern (C1-C2, C3-C4, C5-C6). Notably, the loop between the disulfide-bonded C1 and C2 of the DSL superimposes on the loop from C5 to C6 of the same domain, with an r.m.s. deviation of 0.25 Å ( Supplementary Fig. 2a online) , whereas the stretch of residues from C3 to C6 aligns well with the EGF domains ( Fig. 2c and Supplementary Fig. 2b,c) . On the basis of this structure, we therefore propose that the DSL domain may have evolved from a truncation of two tandem short EGF domains. The sequence immediately upstream of the DSL is not conserved between members of the Notch ligand family, suggesting structural divergence away from the EGF-like fold beyond this point.
The structure of N-1 [11] [12] [13] was solved by molecular replacement using the structure of the first EGF domain from human factor IX (PDB 1EDM) as the search model (Methods). As seen with J-1 DSL-EGF3 , N-1 [11] [12] [13] adopts an extended, gently curving structure ( Fig. 2d) with dimensions of 100 Â 24 Â 20 Å . The model is in overall agreement with the earlier NMR structure obtained for EGF11 and EGF12 in N-1 [11] [12] [13] (r.m.s. deviation ¼ 3.3 Å , Supplementary Fig. 3 online) 23 . The relative orientation of EGF13 in the NMR model could not be accurately determined, probably owing to the lower stability of EGF13 in the absence of a C-terminal tag. Despite this, NOEs were assigned between Tyr482 in EGF12 and Ile509 in EGF13, and these residues are within 3.5 Å of each other in the crystal structure.
A single DSL face mediates both trans-and cis-regulation Sequence alignment of DSL domains from both Jagged/Serrate and Delta-like ligand families identifies a series of highly conserved residues ( Fig. 3a) . Some of these perform a structural role (Supplementary Results online), but others (Phe199, Arg201, Arg203, Asp205, Phe207) are exposed on one face of the DSL domain and form a putative Notch binding site (Fig. 3b) . Calculation of the electrostatic surface potential of the J-1 DSL-EGF3 structure reveals that this region is positively charged and therefore complementary to the binding face on N-1 [11] [12] [13] predicted by NMR (Fig. 3c) . On this basis, we constructed a series of site-directed DSL domain mutants and tested the ability of each to interact with Notch in a well-established in vivo model of Notch activity, the D. melanogaster wing imaginal disc 30 . Alanine substitutions were introduced within the D. melanogaster homolog of J-1, Serrate, at equivalent residues (Phe249, Arg251, Arg253, Asp255 and Phe257) to abrogate function. In addition to mutants containing a single substitution, two additional constructs were made creating double (F249A F257A) and triple (R251A R253A D255A) Serrate mutants. Finally, a nonconserved, surface-exposed residue within the DSL domain, which maps to the uncharged face of the structure and is not predicted to participate in Notch binding (Fig. 3b) , was substituted by alanine (E265A) to act as a positive control; this corresponds to residue Asn215 in the human J-1 DSL domain. (265) 199 (249) 201 (251) 203 (253) 205 (255) 207 (257) Jagged-1 Notch-1 a b c Figure 3 Predicting surfaces involved in binding and recognition. and N-1 11-13 plotted at ± 4 kT e -1 using APBS 54 . Note the positively charged patch (blue) within the DSL domain of Jagged-1 and the negatively charged surface (red) of Notch. The surfaces predicted by sequence/ structure analysis (J-1 DSL-EGF3 ) and NMR studies (N-1 [11] [12] [13] ) to be involved in binding are highlighted by green bands. Serrate wild-type and mutant constructs were expressed in 18 1C fly cultures along the anterior-posterior compartment boundary of the third instar D. melanogaster imaginal wing disc (Methods). The ability of each construct to induce Notch signaling was assayed through the ectopic expression of wingless, a reporter gene for Notch activity (Fig. 4a) , and by the ability of each construct to induce an ectopic wing margin, indicating Serrate activity outside of its usual domain and signaling to Notch in different cells, or to suppress the normal margin of the adult wing, indicating suppression by overexpression in the same cell. Consistent with previous studies, trans-activation of Notch was induced in ventral cells that lay immediately posterior to the stripe of wild-type Serrate overexpression, but was inhibited within the stripe of wild-type Serrate overexpression, through cis-interactions between ligand and receptor (Fig. 4b) . The latter blocked both ectopic Notch signaling and the endogenous Notch activity present at the dorsal-ventral boundary of the wing disc.
Four different classes of Serrate mutants could be distinguished after analysis of wingless expression. Representative images for each class are shown in Figure 4b and images for all mutants can be viewed in Supplementary Fig. 4 online. E265A gave a similar result to the overexpressed wild-type Serrate construct, consistent with its location in the DSL structure on the opposite face of the putative Notch binding surface (Class I). D255A and R251A were able to transactivate Notch in a similar pattern to overexpressed wild-type Serrate but had weaker signaling activity. The ability of these mutants to suppress Notch signaling in the stripe of Serrate-overexpressing cells was also reduced, although still clearly discernable in the form of dorsal-ventral boundary thinning and adult wing notches (Class II). Expression of the F257A mutant had no effect on the wingless reporter gene, neither activating Notch signaling in ventral cells nor repressing endogenous Notch activity at the dorsal-ventral boundary, indicating a key role for this residue in mediating both cis-inhibitory and transactivating interactions with Notch (Class III). Finally F249A and R253A did not induce trans-activation of Notch or cis-inhibition of Notch activity at the dorsal-ventral boundary at 18 1C, but, when expression levels were elevated in 29 1C cultures, both mutants were able to mimic the cis-inhibitory effect of wild-type Serrate at the dorsal-ventral boundary (Class IV). The combination mutants (F249A F257A) and (R251A R253A D255A) also belonged to Class III and were unable to induce trans-activation of Notch or to cis-inhibit Notch ( Table 1) . As expected, the adult wing phenotypes of each mutant class correlated with the ability of Serrate to activate Notch ectopically or inhibit Notch at the dorsal-ventral boundary (Fig. 4b) . Immunostaining revealed that all Serrate mutant constructs were expressed and properly localized at the adherens junction ( Fig. 4b and Supplementary Fig. 5 online) . General comparison of expression levels using immunostained wing discs [11] [12] [13] . Streptavidin-HRP conjugate was used to show that equivalent amounts of N-1 [11] [12] [13] were eluted from the beads for each mutant (below). (c) Surface representations of both J-1 DSL-EGF3 and N-1 [11] [12] [13] are shown in two orientations related by 1801 rotation about the long axis. The J-1 DSL-EGF3 is colored by mutant phenotype class (class 1, green; class II, yellow; class III, red; class IV, orange), whereas the residues implicated in J-1 DSL-EGF3 binding by NMR are colored red on the surface of N-1 [11] [12] [13] . We have termed the faces implicated in binding the 'front' view on each molecule.
showed that the availability of Serrate did not seem limiting for the observed affects of different constructs on wingless expression ( Supplementary Fig. 6 online) . Thus, substitution of all residues predicted by structural data to participate in Notch binding gave functional effects consistent with this prediction. Furthermore, we observed effects of the Serrate mutants on both cis-and trans-interactions, indicating that the Notch binding site identified on the DSL domain is involved in both processes.
Roles for conserved DSL residues in Notch signaling
We carried out cell-aggregation assays with cells transfected with either Serrate or Notch (Figs. 4c and 5a ) to compare the Notch binding ability of different Serrate mutants shown to be defective in Notch trans-activation. Immunofluorescence staining showed that F257A was unable to mediate cell aggregation with Notch-expressing cells, unlike wild-type Serrate or E265A, the control mutant. This suggested that the explanation for the inability of F257A to trans-activate Notch in the wing disc is due to a major defect in Notch binding. Class IV mutants F249A and R253A, however, were each able to promote cellular adhesion and the clustering of ligand and receptor at sites of cellular contact. Therefore, the loss of trans-activation observed in vivo with F249A and R253A is not explained by loss of Notch binding. The fact that F249A and R253A can still bind to Notch in trans (giving rise to a nonsignaling mode) may contribute to their observed ability in vivo to inhibit endogenous Notch signaling at the dorsal-ventral boundary. We further validated these cell-aggregation data using pulldown assays with purified forms of the equivalent human J-1 DSL-EGF3 mutant proteins (Fig. 5b) . In these assays, the mutant constructs were expressed and refolded (as done previously for the wild-type protein; Methods). These proteins were then assayed for the ability to be pulled-down by N-1 [11] [12] [13] coupled to beads via a C-terminal biotin tag (Methods). The results of the pull-down experiments correlated well with the phenotypes observed for the equivalent Serrate mutations in vivo and in the cell-aggregation assays. The N215A (Serrate E265A) control mutant showed wild-type binding, whereas F207A (Serrate F257A) was unable to bind the N-1 11-13 beads. R201A (Serrate R253A) and F199A (Serrate F249A) had intermediate phenotypes, showing reduced, but not abolished, binding in agreement with the other assays.
DISCUSSION
Our multidisciplinary studies have identified for the first time the structure and potential evolutionary origins of a DSL domain, common to all Notch ligands. In addition, we have identified an extended organization of domains within the J-1 DSL-EGF3 ligand fragment, suggesting the possibility of numerous interactions along its surface. Targeted disruption of a conserved, putative Notch binding site in the DSL domain caused both defective cis-inhibition and transactivation of Notch in the D. melanogaster wing, demonstrating that the same surface of the DSL domain is essential for both types of interaction. These data, combined with NMR studies of N-1 [11] [12] [13] that demonstrated a J-1 interaction site at the center of N-1 [11] [12] [13] , identify a candidate interaction surface on both molecules for the Notch-ligand complex (Fig. 5c) . Although we were able to determine structures for functional fragments J-1 DSL-EGF3 and the N-1 11-13 , we were unable to find crystallization conditions compatible with complex formation. We therefore performed in silico docking of J-1 DSL-EGF3 and the N-1 [11] [12] [13] structures (Methods) using restraints from our NMR binding studies (Val453 and Gly472) to drive the docking and then using the J-1 DSL-EGF3 phenotypes to validate the docked models. Notably, the docking predicts two models for the N-1-J-1 interface ( Supplementary   Fig. 7 online) . Both of these models involve interactions along the long axes of the two molecules, but one has the two molecules in a parallel arrangement, whereas the other is antiparallel. In both models the DSL domain has the most prominent role in binding, but EGF1 and EGF2 also participate in interface formation. This is consistent with previous deletion analyses showing that the DSL domain was indispensible for Notch binding, but EGF1 and EGF2 were also required to confer native-like affinity for Notch 26 . The existence of two binding modes could contribute to the exchange broadening observed in the NMR titrations and complicate attempts to crystallize the complex.
That two proteins could interact in completely different ways using the same surfaces is highly unexpected. However, in strong support of this is the observation that all of the J-1 DSL-EGF3 variants that lead to distinct phenotypes when expressed as Serrate mutants in the D. melanogaster wing are buried in the docked models, despite the fact that they were not used to drive the docking. Crucial to both model complexes is the highly conserved phenylalanine residue (Phe207/257), which completely abrogates both trans-activation and cis-inhibition when mutated. This residue packs against the hydrophobic surface formed by Val453 and Gly472 of EGF12 from N-1 11-13. When the two models are compared with the N-1 11-13 considered as a fixed object, they are seen to be related by a 1631 rotation of the J-1 DSL-EGF3 about Phe207. Ring current shifts arising from the aromatic ring may explain in part the larger changes in peak intensity for Val453 and Gly472 observed in the NMR spectrum; these residues could have appreciably different chemical shifts in the free and bound states, which would result in extensive chemical exchange broadening. Notably, the differential outcomes on signal activation obtained from our mutational analysis can be interpreted in the context of the docked models ( Supplementary Fig. 7 ). Residues Phe207, Phe199 and Arg203, which are homologous to those shown to be essential for liganddependent Notch activation by Serrate (Phe257, Phe249 and Arg253), are extensively buried in both models. Residues Arg201 and Asp205 (Arg251 and Asp255 in Serrate), which have a more limited effect, have relatively minor contacts with the N-1 [11] [12] [13] . Given the known cellsurface locations of ligand and receptor, and the knowledge that both J-1 DSL-EGF3 and N-1 [11] [12] [13] form extended structures, we suggest that the parallel complex is a working model for the cis-inhibitory interaction and the antiparallel complex a model for the trans-activating complex of ligand and receptor ( Supplementary Fig. 7) . Different molecular mechanisms underlying the defective transactivation observed in vivo for Serrate mutants F257A, F249A and R253A were revealed by cell-aggregation assays. F257A was unable to mediate adhesion to Notch expressing cells, whereas both F249A (Fig. 4c) and R253A (Fig. 5a ) supported binding. The ability of Serrate F249A and R253A mutants to bind to Notch-expressing cells in aggregation assays, despite the absence of trans-activation in the wing disc experiments, suggests that binding alone is not sufficient for promoting signal initiation. Ligand-dependent activation of Notch has been proposed to involve ligand-dependent clustering of Notchligand complexes at the cellular surface, followed by initiation of a pulling force through the interaction of the Notch and ligand cytoplasmic domains with the endocytic machinery that removes the Notch extracellular domain, which is trans-endocytosed with the ligand into the signal-sending cell 12 . This process then elicits a conformational change in the Notch regulatory region (NRR) 10 . One possible mechanism promoting trans-activation may be a requirement for an interaction of a sufficiently high affinity to resist the tensional force necessary for activation of the NRR. If correct, then the F257A mutant (Phe207 in J-1) may have such a low affinity for Notch that no binding is observed, whereas the F249A (Phe199 in J-1) and R253A (Arg203 in J-1) mutants may allow the complex to form and be sufficiently tight to allow cell aggregation and initiation of receptor clustering, but insufficient to complete the subsequent activation step (Supplementary Fig. 7) . Alternatively, the interactions mediated by Phe199/249 and Arg203/253 may be required to initiate the final activation step by transmitting a conformational change to the cytoplasmic domains of ligand and/or receptor. An interesting possibility is that such a conformational change might be required to initiate the endocytosis of Serrate and hence the trans-endocytosis of Notch. Future studies will analyze in detail the endocytic cycle of the different mutant Serrate constructs.
Genetic mutations in human J-1 are associated with severe disease. Some substitutions affect residues predicted by our study to form part of a Notch-ligand interface. For example, R203K, identified in a patient with extrahepatic biliary atresia 31 , substitutes the highly conserved arginine residue that has been shown in our functional studies (Arg253 in Serrate) to have a crucial role in trans-activation. Similarly, an R252G substitution identified in a patient with Alagille syndrome 32 replaces an arginine involved in a salt bridge at the ligand-receptor interface in both the parallel and antiparallel docking models and is therefore likely to destabilize the interface (Supplementary Fig. 7) .
Signaling via the Notch receptor has been demonstrated to be modulated by Fringe extension of O-fucosylation sites within Notch 33, 34 . The residue in EGF12 of N-1 11-13 (Thr466) that has been suggested to be O-fucosylated and subsequently modified by Fringe is on the opposite face of Notch to that implicated in ligand binding in our model. We therefore predict that O-fucosylation of EGF12 of Notch is not directly involved in J-1 DSL-EGF3 binding, in agreement with the Ca 2+ -dependent specific interaction observed with our unmodified fragments. Furthermore, it has recently been demonstrated that Notch-ligand interactions are not inhibited by the addition of exogenous sugars, also suggesting that the glycosylated residues do not directly contact the ligand 35 . It is also of note that recent work has implicated a novel glucosylase in regulation of Notch activity 36 . Our complexes involve the only potential site of glucosylation in domain 12 and may therefore suggest a role for this modification in modulating ligand interactions.
In summary, we have identified a Notch binding site on the DSL domain from human J-1 that participates in an interface responsible for regulating both cis-and trans-interactions. These data therefore provide the first structural insight into the early events of Notch activation and extend our general understanding of the different ways in which protein-protein complexes may form. Understanding the structural basis of cis-and trans-interactions and the molecular events leading to Notch activation will enable rational approaches to the design of antagonists or agonists of Notch activity, with possible applications in anticancer therapeutics, immune system modulation and the control of cell-fate decisions of stem cells and their progeny in vitro or in vivo.
METHODS
Protein expression and refolding. We carried out expression, purification and refolding of N-1 11-13 as described previously 37 with modifications (Supplementary Methods online) to allow addition of a C-terminal BirA-tag. Biotinylation of N-1 [11] [12] [13] and 15 N-labeling of EGF [11] [12] [13] were performed as described previously 23, 37 . The J-1 DSL-EGF3 fragment was expressed in Escherichia coli NM554 as a His-tag fusion protein and purified from cell lysate by Ni 2+ -affinity chromatography. Native and Selenomethionine (SeMet) material was refolded in vitro and purified as described previously 37 , with modifications as described in Supplementary Methods. Missense mutations to generate F199A, R201A, F207A and N215A in the J-1 DSL-EGF3 construct were introduced into the pQE30 recombinant plasmid containing the cDNA sequence of the wild-type construct by a PCR-based site-directed mutagenesis method with Pfu DNA polymerase. Generation of the desired mutation was confirmed by DNA sequencing. The mutant constructs were purified as described for the wild-type J-1 DSL-EGF3 . Masses were confirmed using electrospray ionization mass spectral analysis (ESI-MS). Correct folding of the functionally dead F207A mutant was confirmed with NMR (data not shown).
Notch antibody. Mouse monoclonal antibodies were generated against purified antigen human N-1 11-14 (ref. 38) and affinity purified.
Pull-down assays. N-1 11-13 (12 mg) and J-1 DSL-EGF3 (3 mg) were incubated in 10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM CaCl 2 , 20 mM imidazole. The 6ÂHis-tagged J-1 DSL-EGF3 fragment was captured on nickel-nitrilotriacetic acid (Ni-NTA) magnetic agarose beads (Qiagen) and washed. Proteins were eluted from the beads, separated using SDS-PAGE and immunostained using the Notch antibody (Fig. 1a) . N-1 [11] [12] [13] was also shown to interact with J-1 DSL-EGF3 previously immobilized on the magnetic beads. The Ca 2+ dependence of the Notch-Jagged interaction was demonstrated by immobilization of biotinylated N-1 11-13 on Dynabeads M-270 Streptavidin (10 mg per 0.5 mg beads), and subsequent capture of J-1 DSL-EGF3 (8 mg per 100 ml) in buffer (10 mM Tris, pH 7.5, 150 mM NaCl) containing 10 mM CaCl 2 or 5 mM EDTA. (Fig. 1b) .
Assaying of binding of J-1 DSL-EGF3 mutants (Fig. 5b) was performed as described above, except that the coeluted N-1 [11] [12] [13] was detected with a streptavidin-horseradish peroxidase (HRP) conjugate.
Surface plasmon resonance. We performed SPR experiments as described in Supplementary Methods. Briefly, J-1 DSL-EGF3 fragment was immobilized on the chip surface and interaction data were collected by injecting N-1 11-13 over the coupled chip surface. Results were identical in the absence (Fig. 1) or presence (data not shown) of the C-terminal BirA tag. Traces were corrected for refractive index changes by subtraction of a control trace that was recorded simultaneously. Unless otherwise stated, all experiments were carried out in TBS, pH 7.5, supplemented with 1mM Ca 2+ .
Nuclear magnetic resonance spectroscopy. NMR data were collected for 0.5 mM 15 N-labeled N-1 11-13 at pH 6.1 with 15 mM Ca 2+ in the absence and in the presence of 0.15 mM unlabeled J-1 DSL-EGF3 (Supplementary Methods). The fractional intensity change, (I bound -I free )/I free , between peaks in the absence (I free ) and presence (I bound ) of J-1 DSL-EGF3 was calculated from peak heights (I); errors were estimated from baseline noise. The fractional intensities in Figure 1f are the average of three experiments.
J-1 DSL-EGF3 crystallization and structure determination. J-1 DSL-EGF3 (residues 187-335) was crystallized in sitting drops by the vapor-diffusion technique at 4.6 mg ml -1 , using 0.2 ml of protein and 0.2 ml of mother liquor. Sparse matrix screening and optimization led to rod-shaped crystals, with approximate dimensions 100 Â 50 Â 20 mm, in 8.5% (w/v) PEG 4000, 100 mM imidazole/malate, pH 7.0. Native and SeMet data sets were collected and processed as described in Table 2 and Supplementary Methods. The structure was phased using autoSHARP 39 and SHARP 40 , built with Xfit 41 , and refined using Buster-TNT 42 ( Table 2) .
N-1 11-13 crystallization and structure determination. N-1 [11] [12] [13] was crystallized in sitting drops by the vapor-diffusion technique at 15.7 mg ml -1 , using 0.2 ml of protein and 0.2 ml of mother liquor. Sparse matrix screening and optimization led to hexahedral crystals, with approximate dimensions 300 Â 100 Â 100 mm, in 30% (w/v) PEG-5000-MME, 100 mM sodium acetate, pH 5.7. Native data were collected and processed as described in Supplementary Methods. The structure was solved by molecular replacement (CCP4-MOLREP 43 ) using three copies of an EGF-like domain from factor IX (PDB 1EDM 44 ) and refined to give the model described in Supplementary Methods and 47 was crossed to each of the UAS-Serrate constructs in either 18 1C or 29 1C fly cultures as indicated in the text. In situ hybridization was performed using a digoxigenin-labeled antisense cRNA wingless probe and stained with alkaline phosphatase-conjugated antidigoxigenin antibody as previously described 48 .
Antibodies for functional analyses. Rabbit polyclonal anti-Serrate 49 was used at a 1:200 dilution. Mouse monoclonal anti-Wingless (4D4) and anti-Notch (C17.9C6) (Developmental Studies Hybridoma Bank, Iowa University) were used at 1:50 and 1:200 dilutions. Anti-rabbit RRX or anti-mouse CY5 secondary antibodies (Jackson Immunoresearch Laboratories) were used at a 1:600 dilution.
Immunocytochemistry. Late third-instar larval discs were dissected in PBS + 0.1% (v/v) Tween20 (PBS-Tw) and fixed in 4% (v/v) formaldehyde/PBS for 20 min at room temperature. The discs were immunostained in PBS + 0.5% (v/v) Triton X-100, 4% (v/v) normal donkey serum. For actin labeling, fluorescein isothiocyanate (FITC)-labeled phalloidin (Sigma) was subsequently incubated with the tissue at 1 mM concentration for 2 h at room temperature, and the tissues were then rinsed five times with PBS-Tw. Preps were transferred into Vectashield mounting medium with DAPI (Vector Laboratories). Images were captured using a cooled digital camera (Hamamatsu) mounted on a Zeiss Axiovert microscope and processed on an Apple Macintosh computer using Improvision Openlab and Adobe PhotoShop software. For images of the adherens junctions, deconvolution was performed using the three nearest neighbors from optical sections obtained with a Z-spacing of 0.5 mm.
Cell culture. Drosophila melanogaster S2 cells (Invitrogen) were transiently transfected as previously described 50 . For Serrate expression, S2 cells were cotransfected with wild-type or mutant pUAST-Ser constructs and pMT-Gal4 51 In silico docking of N-1 [11] [12] [13] and J-1 DSL-EGF3 . Docking was carried out using the program HADDOCK 2.0 (ref. 53) , driving the docking via constraints based on the NMR peak intensity perturbation data observed for N-1 [11] [12] [13] upon complex formation. N-1 [11] [12] [13] residues that showed a significant decrease in peak intensity upon complex formation (Val453 and Gly472) were defined as 'active' . In the absence of NMR data for J-1 DSL-EGF3 , all residues with a high solvent accessibility (450%) were selected as 'passive' residues. The resultant active residues of N-1 [11] [12] [13] and passive residues of J-1 DSL-EGF3 were used to define ambiguous interaction restraints (AIRs) with a distance of 3 Å . Following rigid-body docking, the top ten structures were analyzed and found to belong to two classes. Both of these classes involved interactions along the long axes of the two molecules. The two best-scoring models represented an antiparallel orientation of J-1 DSL-EGF3 relative to N-1 [11] [12] [13] and buried 526 Å 2 per protein.
The next eight models, on the other hand, represented a parallel orientation and buried 857 Å 2 per protein. All ten models buried all of the residues on J-1 DSL-EGF3 that produced phenotypes when mutated in D. melanogaster.
Accession codes. Protein Data Bank: Coordinates for N-1 [11] [12] [13] have been deposited with accession code 2VJ3 and coordinates for J-1 DSL-EGF3 have been deposited with accession code 2VJ2.
